StockData
Avenue Therapeutics, Inc. logo

Avenue Therapeutics, Inc. (ATXI) stock

ATXIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/30
$0.43+0.00 (0.00%)

Close on Oct 16, 2026Market cap $1.42MP/E –Yield –

Avenue Therapeutics cash

Cash and short-term investments held at the end of each period.

Avenue Therapeutics's cash was $1.94M at Jun 30, 2026. For fiscal 2025 it was $2.86M, up 10.1% from the year before. Over ten years it grew 70.2% a year on average. The highest annual figure on record is $21.78M in fiscal 2017.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.86M+10.1%
FY2024Dec 31, 2024$2.59M+45.5%
FY2023Dec 31, 2023$1.78M-73.4%
FY2022Dec 31, 2022$6.71M+78.3%
FY2021Dec 31, 2021$3.76M+20.1%
FY2020Dec 31, 2020$3.13M-64.2%
FY2019Dec 31, 2019$8.75M+227.4%
FY2018Dec 31, 2018$2.67M-87.7%
FY2017Dec 31, 2017$21.78M+10956.9%
FY2016Dec 31, 2016$197.00K+1307.1%
FY2015Dec 31, 2015$14.00K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.94M-41.6%
Q1 FY2026Mar 31, 2026$2.42M-31.0%
Q4 FY2025Dec 31, 2025$2.86M+10.1%
Q3 FY2025Sep 30, 2025$3.71M+42.8%
Q2 FY2025Jun 30, 2025$3.33M-32.4%
Q1 FY2025Mar 31, 2025$3.50M+9.6%
Q4 FY2024Dec 31, 2024$2.59M+45.5%
Q3 FY2024Sep 30, 2024$2.60M+1513.0%
Q2 FY2024Jun 30, 2024$4.92M+213.1%
Q1 FY2024Mar 31, 2024$3.19M-61.2%
Q4 FY2023Dec 31, 2023$1.78M-73.4%
Q3 FY2023Sep 30, 2023$161.00K-25.8%
Q2 FY2023Jun 30, 2023$1.57M+76.5%
Q1 FY2023Mar 31, 2023$8.24M+349.3%
Q4 FY2022Dec 31, 2022$6.71M+78.3%
Q3 FY2022Sep 30, 2022$217.00K-62.9%
Q2 FY2022Jun 30, 2022$890.00K-20.6%
Q1 FY2022Mar 31, 2022$1.83M+0.4%
Q4 FY2021Dec 31, 2021$3.76M+20.1%
Q3 FY2021Sep 30, 2021$585.00K-86.5%
Q2 FY2021Jun 30, 2021$1.12M-78.7%
Q1 FY2021Mar 31, 2021$1.83M-72.2%
Q4 FY2020Dec 31, 2020$3.13M-64.2%
Q3 FY2020Sep 30, 2020$4.33M-68.5%
Q2 FY2020Jun 30, 2020$5.26M-66.0%
Q1 FY2020Mar 31, 2020$6.57M-77.7%
Q4 FY2019Dec 31, 2019$8.75M+227.4%
Q3 FY2019Sep 30, 2019$13.74M+186.0%
Q2 FY2019Jun 30, 2019$15.46M+72.9%
Q1 FY2019Mar 31, 2019$29.45M+96.8%
Q4 FY2018Dec 31, 2018$2.67M-87.7%
Q3 FY2018Sep 30, 2018$4.80M-81.6%
Q2 FY2018Jun 30, 2018$8.94M-74.2%
Q1 FY2018Mar 31, 2018$14.96M+7495.4%
Q4 FY2017Dec 31, 2017$21.78M+72506.7%
Q3 FY2017Sep 30, 2017$26.05M+81306.3%
Q2 FY2017Jun 30, 2017$34.68M–
Q4 FY2016Dec 31, 2016$197.00K–
Q3 FY2016Sep 30, 2016$30.00K–
Q2 FY2016Jun 30, 2016$32.00K–

More Avenue Therapeutics figures

See a number that looks wrong?